Relugolix

Status:
Red
Decision Date:
January 2023
 

Comments

RED: Treatment of adults with advanced hormone-sensitive prostate cancer. NHSE commissioned. (Decision date - March 2023) 

Red Drug Classifications

  • 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app